It has been reported that CD47 is overexpressed in numerous human cancers to escape phagocytosis, and increased CD47 expression is correlated with poor prognosis in various hematologic and solid tumors.14 15 The CD47/SIRPα axis is emerging as a promising target in cancer therapy. The gene discussed is SIRPA; the disease is cancer.